144 related articles for article (PubMed ID: 26359694)
1. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
[TBL] [Abstract][Full Text] [Related]
2. Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis.
Liu CJ; Chang WJ; Chen CY; Sun FJ; Cheng HW; Chen TY; Lin SC; Li WC
Oncotarget; 2015 Oct; 6(30):29268-84. PubMed ID: 26337468
[TBL] [Abstract][Full Text] [Related]
3. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.
Psyrri A; Lee JW; Pectasides E; Vassilakopoulou M; Kosmidis EK; Burtness BA; Rimm DL; Wanebo HJ; Forastiere AA
Clin Cancer Res; 2014 Jun; 20(11):3023-32. PubMed ID: 24700741
[TBL] [Abstract][Full Text] [Related]
4. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic discovery of a theranostic signature (SERPINE1/MMP3/COL1A1/SPP1) for head and neck squamous cell carcinomas and identification of antrocinol as a candidate drug.
Shih ML; Lee JC; Cheng SY; Lawal B; Ho CL; Wu CC; Tzeng DTW; Chen JH; Wu ATH
Comput Biol Med; 2022 Nov; 150():106185. PubMed ID: 37859283
[TBL] [Abstract][Full Text] [Related]
6. Campothecin suppresses cell proliferation and migration in head and neck squamous cell carcinoma by blocking RAB27A-mediated phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT) pathway.
Zhao Y; Wang Y; Zhao L; Qu L; Zheng JH
J Physiol Pharmacol; 2024 Apr; 75(2):205-213. PubMed ID: 38736267
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways.
Lin J; Guan Z; Wang C; Feng L; Zheng Y; Caicedo E; Bearth E; Peng JR; Gaffney P; Ondrey FG
Clin Cancer Res; 2010 Jan; 16(1):77-87. PubMed ID: 20028744
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma.
Gao J; Zhao S; Halstensen TS
Oncol Rep; 2016 Jun; 35(6):3265-74. PubMed ID: 27108527
[TBL] [Abstract][Full Text] [Related]
9. Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study.
Mahjabeen I; Kayani MA
PLoS One; 2016; 11(1):e0146948. PubMed ID: 26785117
[TBL] [Abstract][Full Text] [Related]
10. A novel read-through transcript JMJD7-PLA2G4B regulates head and neck squamous cell carcinoma cell proliferation and survival.
Cheng Y; Wang Y; Li J; Chang I; Wang CY
Oncotarget; 2017 Jan; 8(2):1972-1982. PubMed ID: 28030848
[TBL] [Abstract][Full Text] [Related]
11. NR2F6 as a Prognostic Biomarker in HNSCC.
Klapper L; Ribbat-Idel J; Kuppler P; Paulsen FO; Bruchhage KL; Rades D; Offermann A; Kirfel J; Wollenberg B; Idel C; Perner S
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752295
[TBL] [Abstract][Full Text] [Related]
12. Ah receptor antagonism represses head and neck tumor cell aggressive phenotype.
DiNatale BC; Smith K; John K; Krishnegowda G; Amin SG; Perdew GH
Mol Cancer Res; 2012 Oct; 10(10):1369-79. PubMed ID: 22912337
[TBL] [Abstract][Full Text] [Related]
13. SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma.
Dhanda J; Triantafyllou A; Liloglou T; Kalirai H; Lloyd B; Hanlon R; Shaw RJ; Sibson DR; Risk JM
Br J Cancer; 2014 Nov; 111(11):2114-21. PubMed ID: 25268377
[TBL] [Abstract][Full Text] [Related]
14. Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.
Ausoni S; Boscolo-Rizzo P; Singh B; Da Mosto MC; Spinato G; Tirelli G; Spinato R; Azzarello G
Cancer Metastasis Rev; 2016 Sep; 35(3):413-26. PubMed ID: 27194534
[TBL] [Abstract][Full Text] [Related]
15. Family history of cancer and head and neck cancer survival.
Getz KR; Rozek LS; Peterson LA; Bellile EL; Taylor JMG; Wolf GT; Mondul AM
Laryngoscope; 2017 Aug; 127(8):1816-1820. PubMed ID: 28266024
[TBL] [Abstract][Full Text] [Related]
16. Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas.
Sablin MP; Dubot C; Klijanienko J; Vacher S; Ouafi L; Chemlali W; Caly M; Sastre-Garau X; Lappartient E; Mariani O; Rodriguez J; Jouffroy T; Girod A; Calugaru V; Hoffmann C; Lidereau R; Berger F; Kamal M; Bieche I; Le Tourneau C
Oncotarget; 2016 Jul; 7(30):47418-47430. PubMed ID: 27329726
[TBL] [Abstract][Full Text] [Related]
17. SERPINE1 and SERPINB7 as potential biomarkers for intravenous vitamin C treatment in non-small-cell lung cancer.
Ou J; Liao Q; Du Y; Xi W; Meng Q; Li K; Cai Q; Pang CLK
Free Radic Biol Med; 2023 Nov; 209(Pt 1):96-107. PubMed ID: 37838303
[TBL] [Abstract][Full Text] [Related]
18. Methyl-donor depletion of head and neck cancer cells in vitro establishes a less aggressive tumour cell phenotype.
Hearnden V; Powers HJ; Elmogassabi A; Lowe R; Murdoch C
Eur J Nutr; 2018 Jun; 57(4):1321-1332. PubMed ID: 28251343
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hypoxia-responsive gene expression profile in patients diagnosed with head and neck squamous cell carcinoma.
Matic N; Pettersson L; Sellebjerg F; Lindberg L; Roberg K; Wiechec E
Transl Oncol; 2024 Jan; 39():101841. PubMed ID: 38016355
[TBL] [Abstract][Full Text] [Related]
20. Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation.
Linxweiler M; Schneider M; Körner S; Knebel M; Brust LA; Braun FL; Wemmert S; Wagner M; Hecht M; Schick B; Kühn JP
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
